4NY0 image
Deposition Date 2013-12-10
Release Date 2014-03-12
Last Version Date 2024-03-20
Entry Detail
PDB ID:
4NY0
Keywords:
Title:
Crystal structure of FERM domain of human focal adhesion kinase
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Focal adhesion kinase 1
Gene (Uniprot):PTK2
Mutagens:F85L, W181G
Chain IDs:A (auth: D), B (auth: A), C (auth: B), D (auth: C)
Chain Length:376
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
FAK dimerization controls its kinase-dependent functions at focal adhesions.
Embo J. 33 356 370 (2014)
PMID: 24480479 DOI: 10.1002/embj.201386399

Abstact

Focal adhesion kinase (FAK) controls adhesion-dependent cell motility, survival, and proliferation. FAK has kinase-dependent and kinase-independent functions, both of which play major roles in embryogenesis and tumor invasiveness. The precise mechanisms of FAK activation are not known. Using x-ray crystallography, small angle x-ray scattering, and biochemical and functional analyses, we show that the key step for activation of FAK's kinase-dependent functions--autophosphorylation of tyrosine-397--requires site-specific dimerization of FAK. The dimers form via the association of the N-terminal FERM domain of FAK and are stabilized by an interaction between FERM and the C-terminal FAT domain. FAT binds to a basic motif on FERM that regulates co-activation and nuclear localization. FAK dimerization requires local enrichment, which occurs specifically at focal adhesions. Paxillin plays a dual role, by recruiting FAK to focal adhesions and by reinforcing the FAT:FERM interaction. Our results provide a structural and mechanistic framework to explain how FAK combines multiple stimuli into a site-specific function. The dimer interfaces we describe are promising targets for blocking FAK activation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures